Ken Griffin Seer, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.24 $165 - $224	-100 Reduced 50.0%	100 $0
Q1 2024 May 15, 2024	SELL	$1.54 - $2.09 $308 - $418	-200 Reduced 50.0%	200 $0
Q4 2023 Feb 14, 2024	SELL	$1.47 - $2.22 $9,261 - $13,986	-6,300 Reduced 94.03%	400 $0
Q3 2023 Nov 14, 2023	BUY	$2.18 - $5.52 $7,630 - $19,320	3,500 Added 109.38%	6,700 $14,000
Q2 2023 Aug 14, 2023	SELL	$3.16 - $4.96 $23,700 - $37,200	-7,500 Reduced 70.09%	3,200 $13,000
Q1 2023 May 15, 2023	BUY	$3.6 - $5.88 $25,560 - $41,748	7,100 Added 197.22%	10,700 $41,000
Q4 2022 Feb 14, 2023	BUY	$5.03 - $8.58 $18,108 - $30,888	3,600 New	3,600 $20,000

35.2M

600

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $135M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.